Turinabol 10mg
10 mg · 100 tablets · Oral research compound — Turinabol 10 mg tablets offer a non-aromatising, high-anabolic oral steroid perfect for lean-mass studies and strength-gain research. Its 16-hour half-life supports reliable twice-daily dosing with low water retention and a clear anti-estrogen profile.
€ 39.00
Beschreibung
Turinabol 10 mg Tablets
Marke: Magnus Pharmazeutika
Inhalt: 100 tablets × 10 mg
Total Compound: 1,000 mg per box
Preis: €39
Hergestellt in: Europa
🧪 Produktübersicht
Magnus Pharmaceuticals’ Turinabol (4-Chlorodehydromethyltestosterone) is a Dianabol-derived oral compound known for its high anabolic:low androgenic profile, minimal water retention, and non-aromatising structure. With a ~16-hour half-life and peak plasma levels ~1 hour post-ingestion, it supports twice-daily dosing in lean-mass research and strength-adaptation trials.
Turinabol’s 4-chloro guard reduces estrogenic activity while its 17α-alkylation ensures oral bioavailability—though it introduces hepatic stress in prolonged use. Long detection windows (≥ 2 weeks) and WADA S1 classification make it a reliable positive-control compound in anti-doping validation research.
✅ Die wichtigsten Forschungsergebnisse
-
Precise strength-gain profile with limited virilisation risk
-
Non-aromatising: no estrogenic side effects or water retention
-
PK-backed dosing: t<sub>½</sub> ≈ 16 h, 10 mg twice daily
-
Lean-mass enhancement: improves nitrogen retention & red-cell mass
-
ISO-validated detection via M3/M4 LC-MS/MS metabolites
🔬 Empfohlene Laboranwendungen
-
Androgenic activity vs. aromatisation-free models
-
Muscle strength and body-recomposition studies
-
Doping-assay development (LC-MS/MS workflows)
-
HPTA suppression and recovery investigations
📊 Technische Daten
| Feld | Daten |
|---|---|
| Chemische Bezeichnung | 4-Chlorodehydromethyltestosterone |
| Chemische Formel | C<sub>20</sub>H<sub>27</sub>ClO<sub>2</sub> |
| Synonyme | Turinabol; CDMT; Oral-T; 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one |
| Molekulargewicht | 334.9 g/mol |
| CAS-Nummer | 2446-23-3 |
| Per Tablet | 10 mg (100 tablets per box) |
| Bioavailability | ≈ 100% oral · Renal excretion ≈ 60% of dose |
| Erkennungsfenster | ≥ 2 weeks (M3/M4 metabolites, LC-MS/MS) |
| Haltbarkeitsdauer | 36 months · Store ≤ 25 °C |
⚙️ Pharmacology & Performance Data
| Research Focus | Key Findings |
|---|---|
| Anabolic:Androgenic Index | ~53 anabolic, ~0–6 androgenic (between Dianabol & Oxandrolone) |
| Half-life & Dosing | ~16 h · 10 mg BID dosing keeps plasma active |
| Lean Mass & Strength Effects | Positive nitrogen balance, improved strength, low aromatisation |
| Erythropoietic Action | ↑ Hemoglobin & RBCs in short cycles |
| Water Retention | Minimal due to 4-chloro substitution |
⚠️ Documented Research Risks
| Risk Area | Noted Effects |
|---|---|
| Hepatotoxicity | 17-α alkylation linked to cholestasis & liver enzyme elevation |
| Lipid Disruption | ↓ HDL / ↑ LDL; cardiovascular strain rises with dose and duration |
| CNS/Cardio Activity | ↑ BP, HR, aggression in rodent & athlete models |
| Doping Violation | Detected via WADA S1 banned list & long-term M3/M4 metabolites |
🧯 Handling & Compliance Notice
FOR RESEARCH USE ONLY.
Not intended for human or veterinary administration. Purchase confirms qualified-researcher status and acceptance of all handling and liability protocols. Any exposure will trigger a positive anti-doping result.
Es sind noch keine Bewertungen vorhanden.
